Role of MRI Breast in Detection of Ductal Carcinoma in Situ
- Conditions
- Carcinoma in Situ
- Registration Number
- NCT06744140
- Lead Sponsor
- Superior University
- Brief Summary
"This study investigates the role of Magnetic Resonance Imaging (MRI) in detecting Ductal Carcinoma in situ (DCIS) in high-risk breast cancer patients.
- Detailed Description
Improved detection rates of DCIS in high-risk patients. Enhanced diagnostic accuracy, reducing false positives and negatives. Ductal Carcinoma in situ (DCIS) is a non-invasive breast cancer where abnormal cells are confined to the milk ducts.
The Breast Imaging Reporting and Data System (BI-RADS) is a standardized scoring system used to classify breast imaging findings. Scores range from 0 (incomplete) to 6 (known biopsy-proven malignancy)."
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 35
- High-risk breast cancer patients with a family history of breast cancer or genetic predispositions (e.g., BRCA mutations).
- Patients aged 30-65 years.
- Patients willing to undergo breast MRI screening for DCIS detection.
- Patients with contraindications to MRI imaging (e.g., pacemakers, claustrophobia).
- Patients with a history of prior breast surgery or interventions that may interfere with imaging interpretation.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method sensitivity & specificity 12 Months sensitivity \& specificity of MRI in detecting DCIS
BIRADS scores 12 Months BIRADS scores will be used to evaluate the diagnostic accuracy of MRI in detecting DCIS
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
INMOL hospital
🇵🇰Lahore, Punjab, Pakistan